Literature DB >> 32189489

[Angiotension converting enzyme 2 in the context of 2019 novel coronavirus infection：friend or foe？].

J M Yang1, X Meng1, F Xue1, Y Zhang1, C Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32189489     DOI： 10.3760/cma.j.cn112148-20200303-00149

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN： 0253-3758


× No keyword cloud information.
  3 in total

1.  Scientific statement of the Chinese Society of Cardiology (CSC) on using of renin angiotensin system blockers in patients with cardiovascular disease and COVID-19.

Authors:  Ya-Ling Han; Yu-Ming Li; Chang-Sheng Ma
Journal:  J Geriatr Cardiol       Date:  2020-05       Impact factor: 3.327

2.  Navigating COVID-19 in the developing world.

Authors:  Bridget Hodkinson; Prasun Singh; Ayanda Gcelu; Wilson Bautista-Molano; Guillermo Pons-Estel; Deshiré Alpízar-Rodríguez
Journal:  Clin Rheumatol       Date:  2020-05-27       Impact factor: 2.980

3.  Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension.

Authors:  Xiao Meng; Ya Liu; Chenchen Wei; Kai Zhang; Yi Zhang; Ming Zhong; Cheng Zhang; Yun Zhang
Journal:  Sci China Life Sci       Date:  2020-09-21       Impact factor: 6.038
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.